13G Filing: Armistice Capital and IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Page 10 of 11

Page 10 of 11 – SEC Filing

SIGNATURE

After reasonable
inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.

October 20, 2017
(Date)
Armistice Capital, LLC*
By:  /s/ Steven Boyd
Steven Boyd
Managing Member
Armistice Capital Master Fund Ltd.
By:  /s/ Steven Boyd
Steven Boyd
Director
/s/ Steven Boyd*
Steven Boyd

* This Reporting Person disclaims beneficial
ownership in the Common Stock, except to the extent of his or its pecuniary interest therein.

The original statement shall be signed
by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of
a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of
the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power
of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title
of each person who signs the statement shall be typed or printed beneath his signature.

Note. Schedules filed in paper format
shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for
whom copies are to be sent.

Attention. Intentional misstatements
or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Intellipharmaceutics Intl Inc (NASDAQ:IPCI)

Page 10 of 11